This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Takahiro Katoh: Innovator in Cancer Treatment
Introduction
Takahiro Katoh is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for malignant tumors. His innovative work has garnered attention in the scientific community.
Latest Patents
Takahiro Katoh holds a patent for a compound known as 5-methyl-6-phenyl-4,5-dihydro-2H-pyridazin-3-one derivative. This invention provides an agent for treating malignant tumors, comprising a compound of formula (1). His dedication to advancing medical treatments is evident through this patent.
Career Highlights
Currently, Takahiro Katoh is associated with Otsuka Pharmaceutical Company, Limited. His role at the company allows him to collaborate with other talented professionals in the field. His work is focused on developing innovative solutions to complex medical challenges.
Collaborations
Takahiro has worked alongside notable colleagues such as Masatoshi Iida and Yuki Terauchi. Their combined expertise contributes to the advancement of pharmaceutical research and development.
Conclusion
Takahiro Katoh's contributions to cancer treatment through his innovative patent highlight his importance in the pharmaceutical industry. His work continues to inspire advancements in medical science.